高级检索
当前位置: 首页 > 详情页

NGS-based IgH gene rearrangement monitoring predicts relapse and guides maintenance therapy in DLBCL: A case report from indolent lymphoma to aggressive lymphoma

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Hematology and Hematology Research Institute, West China Hospital, Sichuan University, Chengdu 610044, China [2]Stem Cell Transplantation & Cellular Therapy division, Clinic Trial Center, West China Hospital, Sichuan University, Chengdu 610044, China [3]Department of Pathology, West China Hospital, Sichuan University, Chengdu 610044, China [4]Department of Research and Development, Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China [5]Department of Medicine, Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China
出处:
ISSN:

关键词: Mucosa-associated lymphoid tissue (MALT) lymphoma Diffuse large B cell lymphoma IgH gene rearrangement Mutation Autologous stem cell transplantation

摘要:
This report describes a case of extranodal marginal zone B-cell lymphoma (ENMZL) of the mucosa-associated lymphoid tissue (MALT) lymphoma that transformed to diffuse large B cell lymphoma (DLBCL) in a 39-year-old female patient with Hashimoto's thyroiditis (HT). The patient presented with MALT lymphoma in the thyroid tissue and DLBCL in the multiple site invasions, including the ovary, breast, and lymph nodes. We assessed the Ig gene rearrangement and mutation profile in lymphoma involved tissues and the collected stem cells. V(D)J sequence of the tumor clonotype detected in thyroid, ovary, and breast was identical, revealing a shared origin of the malignant lymphoma. Noticeably, a small percentage of tumor clonotype (the highest-ranking clonotype in tumor tissues) was detected in the stem cell sample, suggesting the malignant cells was residual in the stem cells, likely conferred disease relapse following ASCT. This patient recieved BTK inhibitor combined with radiotherapy to eradicate the residual tumor cells based on the V(D)J sequence monitoring after ASCT. Now the patient remains in complete remission following 12 months of ASCT.Copyright © 2023. Published by Elsevier GmbH.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 病理学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 病理学
第一作者:
第一作者机构: [1]Department of Hematology and Hematology Research Institute, West China Hospital, Sichuan University, Chengdu 610044, China [2]Stem Cell Transplantation & Cellular Therapy division, Clinic Trial Center, West China Hospital, Sichuan University, Chengdu 610044, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号